Haq Naveed Ul, Althaf Mohammed Mahdi, Lee Timmy
Department of Medicine, Section of Nephrology, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia; Division of Nephrology and Hypertension, University of Alabama, Birmingham, AL.
Department of Medicine, Section of Nephrology, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia; Division of Nephrology and Hypertension, University of Alabama, Birmingham, AL.
Adv Chronic Kidney Dis. 2015 Nov;22(6):438-45. doi: 10.1053/j.ackd.2015.08.001.
Early fistula failure (EFF) is a significant clinical problem causing lower rates of arteriovenous fistulae (AVFs) use in patients with ESRD on hemodialysis. The 2 main factors amenable to treatment and widely accepted to cause EFF are stenosis anywhere in the AVF circuit and/or presence of accessory vein (av). The role of stenotic lesions in causing EFF and their treatment options are relatively better defined with clear guidelines. On the other hand, assessing the significance of an av in causing EFF and the indications for its treatment seem to lack scientific recommendations based on robust clinical data. In this article, we review the pathophysiology of EFF as pertains to the presence of av's. Current recommendations for obliteration of av, the available techniques and the evidence to support current clinical practice are discussed. The possible cons of av obliteration are highlighted, while newer concepts and the need for future clinical trials are addressed.
早期内瘘失败(EFF)是一个重大的临床问题,导致接受血液透析的终末期肾病(ESRD)患者动静脉内瘘(AVF)的使用率较低。易于治疗且被广泛认为会导致EFF的两个主要因素是AVF回路中任何部位的狭窄和/或存在副静脉(av)。狭窄病变在导致EFF中的作用及其治疗选择通过明确的指南得到了相对更好的定义。另一方面,评估av在导致EFF中的意义及其治疗指征似乎缺乏基于可靠临床数据的科学建议。在本文中,我们回顾了与av存在相关的EFF的病理生理学。讨论了目前关于av闭塞的建议、可用技术以及支持当前临床实践的证据。强调了av闭塞可能存在的弊端,同时探讨了新的概念以及未来临床试验的必要性。